Innovating to improve health worldwide

Biopharmaceutical CEO Roundtable meets in New York

05 November 2026 – The Biopharmaceutical CEO Roundtable (BCR), bringing together CEOs from leading global biopharmaceutical companies, met in New York on 3–4 November to discuss the changing global policy environment and priorities for strengthening innovation, access, and the long-term competitiveness of the sector.

WIPO’s 38th Standing Committee on Patents: Technology transfer

On 5 November 2026, IFPMA delivered a statement on technology transfer at WIPO’s 38th Standing Committee on Patents. IFPMA notes the study in document SCP/38/9 on collaboration between industry and academia. We welcome the study’s recognition that robust intellectual property frameworks, capable partners, and appropriate financing help turn research into practical applications. Furthermore, we welcome...

WIPO’s 38th Standing Committee on Patents: Patents and health

On 4 November 2026, IFPMA delivered a statement on patents and health at WIPO’s 38th Standing Committee on Patents. A robust, stable, and predictable intellectual property system supports research and development, investment, and voluntary partnerships needed to translate scientific discoveries into innovative medicines and vaccines. As users of the patent system, including the Patent Cooperation...